157 related articles for article (PubMed ID: 6153836)
1. 5-S-cysteinyldopa, dopa, and dopamine in the kidney and some other tissues.
Agrup G; Hansson C; Rorsman H; Rosengren E
Acta Derm Venereol; 1980; 60(1):63-4. PubMed ID: 6153836
[TBL] [Abstract][Full Text] [Related]
2. Determination of DOPA, dopamine, and 5-S-cysteinyl-DOPA in plasma, urine, and tissue samples by high-performance liquid chromatography with electrochemical detection.
Ito S; Kato T; Maruta K; Fujita K; Kurahashi T
J Chromatogr; 1984 Nov; 311(1):154-9. PubMed ID: 6440898
[No Abstract] [Full Text] [Related]
3. Dopa and 5-S-cysteinyldopa in the serum of albino, black, and red guinea pigs.
Hansson C; Agrup G; Rorsman H; Rosengren E
Acta Derm Venereol; 1980; 60(2):155-56. PubMed ID: 6155023
[TBL] [Abstract][Full Text] [Related]
4. Intracellular distribution of dopa and 5-S-cysteinyldopa in Harding-Passey melanoma.
Agrup G; Falck B; Rorsman H; Rosengren AM; Rosengren E
Acta Derm Venereol; 1977; 57(4):313-5. PubMed ID: 70922
[TBL] [Abstract][Full Text] [Related]
5. 5-S-Cysteinyldopa and dopa in serum during treatment with 8-methoxypsoralen and UVA light.
Hansson C; Rorsman H; Rosengren E; Tegner E
Acta Derm Venereol; 1981; 61(3):251-5. PubMed ID: 6167110
[TBL] [Abstract][Full Text] [Related]
6. 5-S-Cysteinyldopa in ganglion stellatum.
Fehling C; Hansson C; Poulsen J; Rorsman H; Rosengren E
J Neural Transm; 1981; 52(3):251-7. PubMed ID: 6796651
[TBL] [Abstract][Full Text] [Related]
7. Urinary excretion of 5-S-cysteinyldopa in patients with primary melanoma or melanoma metastasis.
Agrup G; Agrup P; Andersson T; Falck B; Hansson J-A ; Jacobsson S; Rorsman H; Rosengrem A-M ; Rosengren E
Acta Derm Venereol; 1975; 55(5):337-41. PubMed ID: 52967
[TBL] [Abstract][Full Text] [Related]
8. Effects of L-dopa administration of the concentrations of dopa, dopamine and norepinephrine in various rat tissues.
Romero JA; Lytle LD; Ordonez LA; Wurtman RJ
J Pharmacol Exp Ther; 1973 Jan; 184(1):67-72. PubMed ID: 4686016
[No Abstract] [Full Text] [Related]
9. Cysteinyldopa isomers and dopa in lesions and urine of Japanese patients with malignant melanoma.
Morishima T; Tatsumi F; Fukada E; Saito M; Fujita M; Nagashima N; Hanawa S
Arch Dermatol Res; 1983; 275(2):76-9. PubMed ID: 6409012
[TBL] [Abstract][Full Text] [Related]
10. Protein-bound dopa and 5-S-cysteinyldopa in non-melanogenic tissues.
Ito S; Jimbow K; Kato T; Kiyota M; Fujita K
Acta Derm Venereol; 1983; 63(6):463-7. PubMed ID: 6198833
[TBL] [Abstract][Full Text] [Related]
11. The quantitative determination of 5-S-cysteinyldopa and dopa in normal serum and in serum from patients with malignant melanoma by means of high-pressure liquid chromatography.
Hansson C; Edholm LE; Agrup G; Rorsman H; Rosengren AM; Rosengren E
Clin Chim Acta; 1978 Sep; 88(3):419-27. PubMed ID: 699334
[TBL] [Abstract][Full Text] [Related]
12. Characterization of melanogenesis in mouse and guinea pig hair by chemical analysis of melanins and of free and bound dopa and 5-S-cysteinyldopa.
Ito S; Fujita K; Takahashi H; Jimbow K
J Invest Dermatol; 1984 Jul; 83(1):12-4. PubMed ID: 6429251
[TBL] [Abstract][Full Text] [Related]
13. DOPA in sympathetic nerve tissue--a possible source of serum DOPA in albino animals.
Hansson C; Poulsen J; Rorsman H; Rosengren E
Acta Derm Venereol; 1981; 61(1):69-71. PubMed ID: 6164221
[TBL] [Abstract][Full Text] [Related]
14. Evidence of dopa in the nerves of sea anemones.
Carlberg M
J Neural Transm; 1983; 57(1-2):75-84. PubMed ID: 6137512
[TBL] [Abstract][Full Text] [Related]
15. Presence of cysteinyldopa in the mature bovine eye.
Dryja TP; Albert DM; Rosengren E; Reid TW
Exp Eye Res; 1977 Nov; 25(5):459-64. PubMed ID: 598423
[No Abstract] [Full Text] [Related]
16. Plasma 5-S-cysteinyldopa concentrations in oculocutaneous albinism.
Nimmo JE; Hunter JA; Percy-Robb IW; Jay B; Phillips CI; Taylor WO
Acta Derm Venereol; 1985; 65(2):169-71. PubMed ID: 2408424
[TBL] [Abstract][Full Text] [Related]
17. An improved HPLC-electrochemical detection method for measuring brain levels of 5-S-cysteinyldopamine, 5-S-cysteinyl-3,4-dihydroxyphenylalanine, and 5-S-cysteinyl-3,4-dihydroxyphenylacetic acid.
Fornstedt B; Bergh I; Rosengren E; Carlsson A
J Neurochem; 1990 Feb; 54(2):578-86. PubMed ID: 2105377
[TBL] [Abstract][Full Text] [Related]
18. Urinary 5-S-cysteinyldopa in Parkinsonism after DOPA and carbidopa.
Stewart RM; Miller S; Gunder M
Acta Derm Venereol; 1983; 63(2):97-101. PubMed ID: 6189350
[TBL] [Abstract][Full Text] [Related]
19. [Contents of cysteinyldopa isomers and DOPA in lesions of malignant melanoma (author's transl)].
Morishima T; Saito M; Fujita M; Fukada E; Nagashima N; Hanawa S
Nihon Hifuka Gakkai Zasshi; 1982 Feb; 92(2):157-9. PubMed ID: 6806514
[No Abstract] [Full Text] [Related]
20. Identification of 5-S-cysteinyldopa by high performance liquid chromatography in biopsies from patients with dysplastic melanocytic nevi.
Halldin MM; Cook WS; Kawashima T; Crutcher WA; Fukuyama K
Cancer Res; 1987 Jan; 47(2):636-8. PubMed ID: 3098416
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
